SCHEMBL8600460

SCHEMBL8600460

CCCCCCCCOC(=O)Nc1ccccc1

nearest known ligand 0.84

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.65
NPC1 O15118 8/20 0.65
SMN1; SMN2 Q16637 7/20 0.65
RECQL P46063 1/20 0.65
FAAH O00519 6/20 0.62
HPGD P15428 4/20 0.61
LMNA P02545 3/20 0.61
ALDH1A1 P00352 3/20 0.60
CASP1 P29466 1/20 0.60
KDM4E B2RXH2 1/20 0.60
MAPT P10636 1/20 0.60
MAPK1 P28482 1/20 0.60
MCL1 Q07820 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
EPHX2 P34913 1/20 0.59
TSHR P16473 2/20 0.58
CYP1A2 P05177 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7995030 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL7653371 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL6767997 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL1834100 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL1837292 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL8076542 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL10599124 1.00 RAB9A (0.65) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL8600999 0.98 RAB9A (0.67) RAB9ANPC1SMN1; SMN2RECQLFAAH
SCHEMBL3765824 0.93 RAB9A (0.69) RAB9ANPC1SMN1; SMN2RECQLHPGD
SCHEMBL12411578 0.92 RAB9A (0.69) RAB9ANPC1SMN1; SMN2FAAHHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113024418-B Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2023-01-24 CN claimed
CN-112898184-A Method for continuously synthesizing alicyclic carbamate 河北工业大学 2021-06-04 CN claimed
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-12-26 US disclosed
EP-4431490-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2024-09-18 EP disclosed
CN-118215651-A Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition 旭化成株式会社 2024-06-18 CN disclosed
CN-113024418-B Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2023-01-24 CN disclosed
EP-3838892-B1 METHOD FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2022-10-12 EP disclosed
CN-113024418-A Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2021-06-25 CN disclosed
CN-112898184-A Method for continuously synthesizing alicyclic carbamate 河北工业大学 2021-06-04 CN disclosed
US-20210095067-A1 URETHANE EXCHANGE CATALYSTS AND METHODS FOR REPROCESSING CROSS-LINKED POLYURETHANES NATIONAL SCIENCE FOUNDATION 2021-04-01 US disclosed
CN-105026367-B Method for producing isothiocyanate 旭化成株式会社 2019-05-21 CN disclosed
CN-103097348-A Process for producing carbonyl compounds ASAHI KASEI CHEMICALS CORP (JP) 2013-05-08 CN disclosed
CN-102471244-A Process for producing N-substituted carbamate, process for producing isocyanate using the N-substituted carbamate, and composition for transporting and storing N-substituted carbamate containing N-substituted carbamate and aromatic hydroxy compound ASAHI KASEI CHEMICALS CORP (JP) 2012-05-23 CN disclosed
CN-101747234-A Method for synthesizing phenyl carbamate UNIV HENAN NORMAL 2010-06-23 CN disclosed
CN-1966490-A Process for preparing amido formate LANZHOU CHEM PHYS INST (CN) 2007-05-23 CN disclosed
EP-0520377-B1 A process for the selective preparation of 4,4-methylene-bis-(N-phenylalkylcarbamate) LUCKY LTD (KR) 1998-02-25 EP disclosed
US-5384424-A Methylating N-phenylalkylcarbamate using acid catalyst LUCKY LIMITED (KR) 1995-01-24 US disclosed
EP-0520377-A2 A process for the selective preparation of 4,4-methylene-bis-(N-phenylalkylcarbamate) LUCKY LTD. (KR) 1992-12-30 EP disclosed
US-4487713-A HEAT TREATMENT WITH TITANIUM, TIN, ANTIMONY OR ZIRCONIUM COMPOUND EXXON RESEARCH & ENGINEERING CO. (US) 1984-12-11 US disclosed
US-4081472-A CATALYTIC, FROM A CARBAMATE MITSUI TOATSU CHEMICALS INC. (JA) 1978-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION IDH3A, CA7, C9 RAB9A 3205/4885NPC1 666/4885SMN1; SMN2 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.